Q32 Bio Inc.
QTTB
$1.94
$0.052.65%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 44.11% | -1,172.01% | 47.58% | -25.40% | -192.37% |
| Total Depreciation and Amortization | -24.79% | -3.25% | -3.23% | -0.81% | -2.42% |
| Total Amortization of Deferred Charges | -25.76% | 65.52% | 63.33% | 614.29% | 164.00% |
| Total Other Non-Cash Items | 50.71% | 104.01% | -13.06% | -82.38% | 255.36% |
| Change in Net Operating Assets | 50.99% | -286.28% | -93.21% | -114.19% | -39.27% |
| Cash from Operations | 52.05% | 14.22% | -6.65% | -222.77% | -95.43% |
| Capital Expenditure | -- | -- | -- | -5,700.00% | -1,600.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 994,300.00% | 988,700.00% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | -- |
| Issuance of Common Stock | -- | -- | 317.11% | -- | 2,433.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 317.11% | 232.33% | -36,913.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 40.32% | -114.70% | -4.46% | -152.98% | -57.24% |